EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, MAY 1, 2020
Media advisory: The full study and editorial are linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamacardiology/fullarticle/10.1001/jamacardio.2020.1787?guestAccessKey=ae7dcc34-5c46-43e6-afb7-808994158cbe&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=050120
What The Study Did: Case series assesses QT intervals for French patients with coronavirus disease 2019 (COVID-19) treated with hydroxychloroquine alone or in combination with azithromycin.
Authors: Martin Cour, M.D., Ph.D., of the Hôpital Edouard Herriot in Lyon, France, is the corresponding author.
Editor’s Note: Please see the articles for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.